Ambar Protein Closes Trading Window April 1 for Q4 Results

CHEMICALS
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Ambar Protein Closes Trading Window April 1 for Q4 Results
Overview

Ambar Protein Industries announced its trading window will close starting April 1, 2026. The restriction will remain in place until 48 hours after the company declares its audited financial results for the quarter and year ended March 31, 2026. This action complies with SEBI regulations to prevent insider trading of sensitive information.

Ambar Protein Industries Closes Trading Window for Q4 FY26 Results

Ambar Protein Industries will close its trading window from April 1, 2026. This is to prevent insider trading before the company releases its audited financial results for the quarter and full fiscal year ending March 31, 2026.

Trading Window Closure Details

The company's trading window for company shares will shut down starting April 1, 2026. This restriction will remain in effect until 48 hours after the audited financial results for the fourth quarter and fiscal year ending March 31, 2026, are officially announced.

Designated individuals, including directors and employees, have been informed and are prohibited from trading in the company's securities during this period. This action adheres to SEBI regulations and the company's internal code of conduct, aiming to stop the misuse of non-public, price-sensitive information.

Why This Matters to Investors

This standard procedural step is vital for maintaining market fairness and ensuring all investors have access to information simultaneously. By halting trading ahead of earnings announcements, Ambar Protein Industries upholds SEBI's rules against insider trading and promotes transparent disclosure practices.

Company Background and Previous Scrutiny

Ambar Protein Industries, founded in 1992, produces edible oils and other products under the 'Ankur' brand. The company operates with a royalty-free license for the brand, which helps with recognition, particularly in Gujarat.

The company has previously faced regulatory attention. In September 2024, the BSE fined Ambar Protein ₹21,240 for failing to submit its corporate governance compliance report on time.

Financially, Ambar Protein operates with moderate profits. This is attributed to low value addition in its products, fluctuating raw material costs, and tight liquidity. For the fiscal year 2024, the company reported total operating income of ₹337 crore and a net worth of ₹25.50 crore. In 2017, the company had requested an extension for its financial results submission, citing the transition to IND-AS accounting standards.

Impact on Designated Employees

Employees and directors classified as "designated persons" by the company are now forbidden from buying or selling Ambar Protein shares while the trading window is closed. This measure is designed to prevent any trading based on the upcoming, yet-to-be-released financial figures.

Key Risks for Ambar Protein

  • Delayed Financial Results: Any significant delays in announcing the audited financial results could extend the trading ban for company insiders.
  • Raw Material Price Swings: Fluctuations in the cost of key raw materials, such as cotton seed, can impact the company's profitability.
  • Liquidity Pressures: The company faces challenges related to stretched liquidity and high utilization of its fund-based credit lines, which could affect its short-term financial flexibility.

Comparison with Industry Peers

Ambar Protein Industries is a small-cap company with a market capitalization typically around ₹90-100 crore. This is considerably smaller than major players in the sector like Marico and Patanjali Foods, which boast market capitalizations in the tens of thousands of crores.

The company currently has a dividend yield of 0.00%. While it has reported profits, Ambar Protein Industries has not issued dividends to its shareholders, unlike potentially larger, more established competitors.

Financial Performance Trends

Over the past five fiscal years (FY20-FY25), Ambar Protein Industries has shown modest sales growth of 8.18%. However, the company has achieved strong profit growth of 29.43% over the last three fiscal years (FY22-FY24).

What to Watch Next

Investors and stakeholders should monitor the official announcement date for Ambar Protein Industries' audited financial results for the quarter and fiscal year ending March 31, 2026. The upcoming results statement will provide details on the company's financial performance and any further commentary from management. Updates on when the trading window will reopen will also be important.

Disclaimer:This content is for informational purposes only and does not constitute financial or investment advice. Readers should consult a SEBI-registered advisor before making decisions. Investments are subject to market risks, and past performance does not guarantee future results. The publisher and authors are not liable for any losses. Accuracy and completeness are not guaranteed, and views expressed may not reflect the publication’s editorial stance.